Parent Terms |
Term With Siblings |
Child Terms |
|
(1'x,2S)-2-(1,2-Dihydroxy-1-methylethyl)-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-7-one 2'-glucoside
(R)-Byakangelicin 2'-glucoside
(R)-Byakangelicin 3'-glucoside
(R)-Byakangelicinn 2'-(3-methylbutanoate)
(R)-Heraclenol 2'-(3-methyl-2-butenoate)
(R)-Heraclenol 2'-(3-methylbutanoate)
(R)-Isobyakangelicin 3'-glucoside
(R)-Rutaretin 1'-(6''-sinapoylglucoside)
2-(2-Hydroxypropan-2-yl)-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrofuro[3,2-g]chromen-7-one
3,4,5-trihydroxy-6-(\{2-[6-(1-hydroxy-2-methylbut-3-en-2-yl)-7-oxo-2H,3H,7H-furo[3,2-g]chromen-2-yl]propan-2-yl\}oxy)oxane-2-carboxylic acid
3,4,5-trihydroxy-6-(\{2-[6-(2-methylbut-3-en-2-yl)-7-oxo-2H,3H,7H-furo[3,2-g]chromen-2-yl]propan-2-yl\}oxy)oxane-2-carboxylic acid
3,4,5-trihydroxy-6-[(2-\{7-oxo-2H,3H,7H-furo[3,2-g]chromen-2-yl\}propan-2-yl)oxy]oxane-2-carboxylic acid
3,4,5-trihydroxy-6-\{2-hydroxy-2-[6-(2-methylbut-3-en-2-yl)-7-oxo-2H,3H,7H-furo[3,2-g]chromen-2-yl]propoxy\}oxane-2-carboxylic acid
3,4,5-trihydroxy-6-\{[3-hydroxy-4-(\{4-methoxy-7-oxo-7H-furo[3,2-g]chromen-9-yl\}oxy)-2-methylbutan-2-yl]oxy\}oxane-2-carboxylic acid
3,9-dihydroxy-2-(2-hydroxypropan-2-yl)-2H,3H,7H-furo[3,2-g]chromen-7-one
3-(3,5-dimethyl-7-oxo-6-furo[3,2-g][1]benzopyranyl)propanoic acid
3-(ethoxycarbonyl)psoralen
3-hydroxy-2-(2-hydroxypropan-2-yl)-2H,3H,7H-furo[3,2-g]chromen-7-one
3-hydroxy-2-(2-hydroxypropan-2-yl)-6-(2-methylbut-3-en-2-yl)-2H,3H,7H-furo[3,2-g]chromen-7-one
3-methyl-5-propyl-7-furo[3,2-g][1]benzopyranone
4-(2,3-Dihydroxy-3-methylbutoxy)furo(3,2-g)chromen-7-one
4-[(2S)-2-hydroxy-3-methyl-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]butoxy]-7-furo[3,2-g][1]benzopyranone
4-[2-Hydroxy-3-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutoxy]furo[3,2-g]chromen-7-one
4-methoxy-9-(2-methylbut-3-en-2-yl)-7H-furo[3,2-g]chromen-7-one
4-methoxy-9-(3-methylbut-2-en-1-yl)-7H-furo[3,2-g]chromen-7-one
5-aminolevulinic acid hydrochloride
5-methoxy-8-(2'-hydroxy-3'-buthoxy-3'-methylbutyloxy)psoralen
5-methyl-8-(3-methylbut-2-enyl) furanocoumarin
6',7'-Dihydroxybergamottin
6-(1-hydroxy-2-methylbut-3-en-2-yl)-2-(2-hydroxypropan-2-yl)-2H,3H,7H-furo[3,2-g]chromen-7-one
9-(2,3-dihydroxy-3-methylbutoxy)-7-furo[3,2-g][1]benzopyranone
9-Hydroxy-4-(3,7-dimethyl-2,6-octadienyloxy)-psoralen
9-Hydroxy-4-methoxypsoralen
[2-(2-Acetyloxypropan-2-yl)-7-oxo-2,3-dihydrofuro[3,2-g]chromen-3-yl] 2-methylpropanoate
[3-Hydroxy-1-(4-methoxy-7-oxofuro[3,2-g]chromen-9-yl)oxy-3-methylbutan-2-yl] (E)-2-methylbut-2-enoate
\{2-hydroxy-2-[6-(2-methylbut-3-en-2-yl)-7-oxo-2H,3H,7H-furo[3,2-g]chromen-2-yl]propoxy\}sulfonic acid
acetic acid 2-(7-oxo-2,3-dihydrofuro[3,2-g][1]benzopyran-2-yl)propan-2-yl ester
benzoic acid 2-[(2S)-7-oxo-2,3-dihydrofuro[3,2-g][1]benzopyran-2-yl]propan-2-yl ester
decarboxytiaprofenic acid
Isopropylidenylacetyl-marmesin
lomefloxacin hydrochloride
meso-tetrakis(N-methyl-4-pyridyl)porphine tetrakis(p-toluenesulfonate)
meso-tetrakis(N-methyl-4-pyridyl)porphine(4+) +
methyl 5-aminolevulinate +
methyl 5-aminolevulinate hydrochloride
polyhexamethylene biguanide hydrochloride
trioxsalen 7H-Furo[3,2-g]chromen-7-one in which positions 2, 5, and 9 are substituted by methyl groups. Like other psoralens, trioxsalen causes photosensitization of the skin. It is administered orally in conjunction with UV-A for phototherapy treatment of vitiligo. After photoactivation it creates interstrand cross-links in DNA, inhibiting DNA synthesis and cell division, and can lead to cell injury; recovery from the cell injury may be followed by increased melanisation of the epidermis.
|
|
|
Synonyms |
Exact Synonyms: |
2,5,9-trimethyl-7H-furo[3,2-g]chromen-7-one
|
Related Synonyms: |
2',4,8-Trimethylpsoralen
;
4,8,5'-Trimethylpsoralen
;
6-hydroxy-beta,2,7-trimethyl-5-benzofuranacrylic acid, delta-lactone
;
Formula=C14H12O3
;
InChI=1S/C14H12O3/c1-7-4-12(15)17-14-9(3)13-10(6-11(7)14)5-8(2)16-13/h4-6H,1-3H3
;
InChIKey=FMHHVULEAZTJMA-UHFFFAOYSA-N
;
SMILES=Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1
;
Trimethylpsoralen
;
trioxisaleno
;
trioxysalen
|
Alternate IDs: |
CHEBI:1758
;
CHEBI:20282
|
Xrefs: |
Beilstein:221723
;
CAS:3902-71-4
;
DrugBank:DB04571
;
Drug_Central:2759
;
KEGG:C09314
;
KEGG:D01034
;
KNApSAcK:C00002502
;
LINCS:LSM-3223
|
Xref Mesh: |
MESH:D014307
|
Xrefs: |
Patent:US3201421
;
Wikipedia:Trioxsalen |
|